A pharmaceutical company targeting unmet clinical needs.

Herantis Pharma was created by a merger of two pharmaceutical companies, Hermo Pharma and Laurantis Pharma.

Pipeline

Overview

Herantis has a product development portfolio focused in areas of unmet clinical need, based on internationally recognized science.

Read More

Herantis Pharma's Lymfactin study advances to last patient cohort, company announces initial plans for continued development

Herantis Pharma's Lymfactin study advances to last patient cohort, company announces initial plans for continued development Herantis Pharma Plc Company…

Read More

Herantis Pharma's clinical study with CDNF in Parkinson's disease authorized in Finland, company expands on development plan

Herantis Pharma's clinical study with CDNF in Parkinson's disease authorized in Finland, company expands on development plan Herantis Pharma Plc…

Read More

Herantis Pharma granted a U.S. patent on therapeutic use of MANF

Herantis Pharma granted a U.S. patent on therapeutic use of MANF Herantis Pharma Plc Company release 23 May 2017 at…

Read More

Investors

Herantis shares are listed on NASDAQ OMX Helsinki First North Finland. Read More

New therapies for a better life.